|
Newsletter 2023 Jan & Feb
2023年1&2月简报
|
|
About Us 国际微无创医学会简介
|
The International Society of Minimally Invasive and Virtual Surgery (ISMIVS, previously known as International Society of Minimally Invasive and Noninvasive Medicine) was founded in July 2013 at the gala of the 1st Yangtze International Summit of Minimally Invasive and Noninvasive Medicine in Chongqing, China. ISMIVS envisions to accelerating the progress in minimally invasive and noninvasive medicine by promoting research, education, communication, and international collaboration.
国际微无创医学会（ISMIVS）是在 2013 年 7 月在中国重庆召开的第一届国际微无创医学长江高峰论坛上宣布成立的，旨在通过学术研究、教育、交流以及国际合作加快微无创医学的发展。
|
|
Become a member 注册成为会员 >
|
|
The Personality in the Medical Education World 医学教育界的大人物
|
From the 2020 July issue of our ISMIVS Newsletter, we would like to introduce some pioneers in the field of minimally-invasive and noninvasive medicine. They are not only prestigious in their field but also willing to share their experience and ideas with younger doctors, hence making a great contribution to medical education. This issue features Shaheen Khazali, a leading expert in endometriosis from Britain.
从 2020 年 7 月刊开始，国际微无创医学会将为大家介绍微无创医学领域的一些领军人物。他们不仅在各自的领域享负盛名，而且非常乐意与年轻医生分享他们的经验、理念和想法，从而为医学教育做出了巨大的贡献。本期月刊要介绍的是英国妇科內异症专家 Shaheen Khazali 教授。
|
|
|
Prof. Shaheen Khazali
MD MRCOG MSc
Consultant Gynaecologist and Endometriosis Surgeon
Centre for Endometriosis and Minimally Invasive Gynaecology (CEMIG)
Shaheen Khazali教授
医学博士、皇家妇产科医学院院士、理科硕士
妇科专家及子宫內异症外科顾问
Consultant Gynaecologist and Endometriosis Surgeon, HCA The Lister Hospital, Chelsea, London & Ashford and St. Peter’s Hospital NHS Foundation Trust, Chertsey, Surrey.
Honorary Senior Lecturer, Royal Holloway-University of London
Honorary Secretary, International Society of Neuropelveology (ISON)
伦敦切尔西HCA The Lister Hospital及切特西萨里郡国民健康基金会信托基金会（NHS Foundation Trust）Ashford and St. Peter’s Hospital，妇科专家及子宫內异症外科顾问
伦敦大学皇家霍洛威学院荣誉高级讲师
国际神经生物学会（ISON）名誉秘书
Prof. Khazali is an internationally renowned expert in advanced robotic and laparoscopic endometriosis surgery and in minimally invasive gynaecology. His practice is almost exclusively dedicated to looking after women with the most severe forms of endometriosis when the disease has affected other organs such as the bowel, bladder, ureters and pelvic nerves.
Khazali 教授是先进机器人和腹腔镜子宫内膜异位症手术和微创妇科方面的国际知名专家。他致力于疗愈患有严重子宫内膜异位症的妇女，因为该病将累及病患的其他器官，如肠道、膀胱、输尿管和盆腔神经。
He also sees and treats women with other benign gynaecological conditions such as heavy menstrual bleeding, ovarian cysts and menstrual disorders. Almost all of Prof. Khazali’s procedures are performed either robotically (da Vinci Xi) or laparoscopically
他还诊治患有其他良性妇科疾病的妇女，如大量月经出血、卵巢囊肿和月经紊乱。Khazali 教授通常通过第四代达芬奇手术机器人或腹腔镜进行妇科手术。
Prof. Khazali has a passion for training other gynaecologists who wish to become endometriosis surgeons or those who want to acquire advanced skills in gynaecological surgery. He has trained many surgeons who are now leading centres of excellence both in the UK and abroad.
Khazali 教授也十分热心于培训其他希望成为子宫内膜异位症外科医生或希望获得妇科手术高级技能的妇科医生。他培训的众多外科医生都成为了英国国内外卓越中心的领导者。
He is regularly invited to speak at national and international conferences on topics related to advanced minimally invasive gynaecology. Prof. Khazali has led several innovative projects, including an online pain diary for chronic pelvic pain patients, the development of a new laparoscopic instrument to improve the safety and speed of surgery and devised a scoring system for assessing laparoscopic surgical skills of trainees. For now, he is involved in the primary study with Oxford University of high-intensity focused ultrasound (HIFU), an innovative noninvasive technology, in the treatment of endometriosis.
他时常受邀作为主题讲者在英国和国际会议上就先进的微创妇科技术发言。Khazali 教授领导了许多创新科研项目，包括为慢性盆腔疼痛患者提供线上的疼痛记录日记，开发新的腹腔镜器械以提高手术的安全性和速度，还设计了一套评估受训者腹腔镜手术技能的评分系统。目前，他正与牛津大学合作，研究高强度聚焦超声（HIFU）治疗子宫内膜异位症这一创新的无创技术。
|
|
Read his article on laparoscopic excision:
|
|
https://pubmed.ncbi.nlm.nih.gov/30953187/
|
|
阅读Khazali教授在腹腔镜切除术方面的文章：
|
|
https://pubmed.ncbi.nlm.nih.gov/30953187/
|
|
News 新闻
|
Successfully Closed: 2022 Annual Recognition Ceremony for Outstanding Institutions/Individuals in Clinical Application and Research of Ultrasound Therapy
2022 年度超声治疗技术临床应用及科研优秀单位/个人表彰仪式圆满落幕！
|
|
|
|
State Key Laboratory of Ultrasound in Medicine and Engineering was originally developed by a research group on ultrasound biological effects, which has a history of 35 years. The team has initially established the basic theoretical system of focused ultrasound therapy, broken through a series of key technologies of focused ultrasound therapy, and developed the world's first major ultrasound therapy medical device made in China.
超声医学工程国家重点实验室是最初的超声生物学效应课题组发展起来的，至今已有 35 年的历史，团队已经初步建立了聚焦超声治疗的基础理论体系，突破聚焦超声治疗系列关键技术，研发出全球首台中国原创超声治疗大型医疗设备。
At present, as a response to calls from the medical field, the State Key Laboratory of Ultrasound in Medicine and Engineering (SKLUME), as well as the National Engineering Research Center of Ultrasound Medicine of China (NERCUM) have established the theoretical system of biological effects of focused ultrasound in collaboration with High-Intensity Focused Ultrasound (HIFU) Centers, successfully built the "foundation" of the field of focused ultrasound, on which both majors of medicine and engineering have been integrated and developed. Through strategies such as specialist training, specific-field-oriented talent training, an alliance of HIFU Centers, and university-institute cooperation, the whole industry chain has been held together, including basic research in the original invention, basic research for application, application and transformation research, as well as major application research. Therefore, a model of a linked innovation chain and industry chain, and synergistic development of industry-university-research-application, is born. In the future, in-depth cooperation will be carried out with HIFU Centers at home and abroad in scientific and technological innovation, talent training and public service, so as to provide more patients with high-quality medical services that suffer less harm.
目前，在医学需求牵引下，超声医学工程国家重点实验室、超声医疗国家工程研究中心协同应用医院等，建立了聚焦超声生物学效应理论体系，成功搭建聚焦超声领域的「地基」，在此基础上实现了医学、工程「双塔」融通发展。通过专科医生培养、领域人才培养、应用医院联盟、高校院所合作等，贯穿了原始创造基础研究、应用基础研究、应用转化研究、重大应用研究整个链条，实现了创新链和产业链联动、产学研用协同发展的模式。未来，将在科技创新、人才培养与服务社会等方面与国内外临床应用医院开展深度合作，为更多患者提供受伤害更小的高品质医疗服务。
|
|
|
|
On February 25, the “2022 Annual Recognition Ceremony for Outstanding Institutions/Individuals in Clinical Application and Research of Ultrasound Therapy” hosted by the State Key Laboratory of Ultrasound in Medicine and Engineering was successfully concluded.
2 月 25 日，由超声医学工程国家重点实验室主办的「2022 年度超声治疗技术临床应用及科研优秀单位/个人表彰仪式」圆满落幕。
To reward HIFU Centers that are excellent in conducting major projects opened by SKLUME, as well as publishing research articles, the Award of Excellent R&D Institutions of Ultrasound Therapy goes to:
五家 HIFU 临床应用单位获「超声治疗技术优秀临床科研单位」奖项，他们在开展超声治疗技术相关国重开放课题、各级课题、论文发表等方面名列前茅，分别是：
|
|
|
|
To honour HIFU Centers that have made special contributions in indication exploring and project cooperation, the Contribution Award of Institutions in Clinical Trial of Ultrasound Therapy goes to:
共九家 HIFU 临床应用单位获「超声治疗技术临床试验特别贡献单位」奖项，他们在超声治疗技术临床适应症拓展、项目合作等方面做出了特别贡献，分别是：
|
|
|
|
To honour the top 10 clinical centres with the highest number of treatment cases in 2022, the Award of Best Institutions of Clinical Application in Ultrasound Therapy goes to:
2022 年HIFU临床治疗量全国排名前十的临床应用单位获得「超声治疗技术临床应用优秀单位」奖项，分别是：
|
|
|
|
In addition, the First People's Hospital of Foshan won the Improvement Award for Clinical Application in Ultrasound Therapy in light of the significant rising from 120 HIFU cases in 2021 to 420 HIFU cases in 2022.
佛山市第一人民医院是 2022 年治疗量进步最大的 HIFU 临床应用单位，创造了治疗量由 2021 年的 120 例到 2022 年达到 420 例的优秀成绩，获「超声治疗技术临床应用特别进步单位」奖项。
|
|
Case Studies 病例分享
|
|
|
While there are clear limitations to the methodology of case studies in the determination of treatment protocol and establishment of new trials, the observation of a single patient can add to our understanding of aetiology, pathogenesis, natural history, treatment option and complications to promote the medical development of a particular disease, and to the clinical practice of potential junior investigators.
尽管病例研究方法在确定治疗方案、组织新的临床试验方面存在明显局限性，但对单个病例的观察研究可以帮助我们了解病因、发病机制、自然病程、治疗方法及并发症，从而促进特定疾病的医学发展，并助益初级研究人员的临床实践。
The case below was shared by Prof. Mohamed Hamed, assistant professor of Radiology and Interventional Radiology at Cairo University in Egypt, at the 2022 APAGE-OGSM-ISMIVS Conference of Minimally Invasive and Noninvasive Surgery (Malaysia)
本期病例由埃及开罗大学 Mohamed Hamed 教授于 2022 年 APAGE-OGSM-ISMIVS 微无创治疗联合会议上分享。
|
|
|
Patient Info 患者信息
36 years old female
Complaining of abnormal uterine bleeding
Symptoms relieved after HIFU treatment
36岁女性，子宫异常出血，接受 HIFU 治疗后症状缓解。
|
|
Watch the whole meeting >
|
|
Notice 通知
|
The 5th Yangtze International Summit of Minimally Invasive and Noninvasive Medicine (ISMINIM)
第五届国际微无创医学长江高峰论坛（ISMINIM）
|
|
|
|
With great pleasure, we are excited to invite you to ISMINIM 2023, the Yangtze International Summit of Minimally Invasive and Noninvasive Medicine which will reboot in Chongqing during 8-9 July 2023,
我们非常高兴地宣布，第五届国际微无创医学长江高峰论坛（ISMINIM）将于 2023 年 7 月 8 日至 9 日举行。
From 2013 to 2019, we worked hard to make ISMINIM a strong and successful event, bringing all active and interested physicians in the field of minimally invasive and noninvasive medicine together. After three years of expectation for the ISMINIM family to reunite, this year, the Summit will again address the applicability of the latest technology developed in disease management, for the benefit of the primary purpose, of minimizing harm to patients.
从 2013 年到 2019 年，ISMINIM 已成为具有国际影响力的重大盛会，将所有活跃在微无创领域的医生同僚聚集在一起。ISMINIM 因疫情影响已搁置三年，在大家的殷切期待下，我们终于能够在重庆再次相见。今年，峰会将贯彻国际微无创医学会的理念，探讨最新的微无创技术在疾病管理中的适用性，将对患者的伤害降到最低。
|
|
The 1st Announcement:
|
|
ISMINIM 2023
|
|
How to apply:
|
|
Registration
|
The 23rd APAGE Annual Congress
亚太妇产科内视镜暨微创治疗医学会（APAGE）第23届年会
|
|
|
|
The 23rd APAGE Annual Congress will be held on October 26-28, 2023, in Singapore, please kindly save the date and see you there!
APAGE 第 23 届年会将于 2023 年 10 月 26 日 至 28 日在新加坡举行，欢迎大家参与！
|
|
General enquiries 信息咨询：
|
|
apage2023.enquiry@gmail.com
|
|
Registration 年会注册：
|
|
apage2023.reg@gmail.com
|
|
Abstract 摘要投稿：
|
|
aapage2023.abstract@gmail.com
|
|
HIFU Special Issue 高强度聚焦超声特刊
|
|
We are delighted to announce that the International Journal of Hyperthermia, the HIFU Special Issue (i.e. Volume 38, 2021), which was partially supported by ISMIVS, was officially released in September. The Special Issue includes 15 articles written and reviewed by world-renowned scholars and pioneers in minimally invasive and noninvasive medicine, elaborating on the status and prospects of the clinical applications of high intensity focused ultrasound on tumours that occurred in specific organs. We'll share the 15 articles included in the upcoming newsletters, stay tuned!
我们很高兴地向大家宣布，由国际微无创医学会（ISMIVS）参与并大力支持的《国际热疗杂志：高强度聚焦超声（HIFU）特刊》已于九月正式发布。本期特刊邀请到多位微无创医学领域的国际知名专家和行业先驱参与编撰及审核，共包含15篇学术文章，阐述了高强度聚焦超声（HIFU）治疗人体各器官肿瘤的临床应用现状和发展前景。我们将陆续分享HIFU特刊中的文章，敬请期待！
|
The safety and ablation efficacy of ultrasound-guided high-intensity focused ultrasound ablation for desmoid tumors
超声引导的高强度聚焦超声消融治疗硬纤维瘤的安全性和消融效果
|
|
This article is to evaluate the safety and efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for desmoid tumours (DTs).
本文旨在评估超声引导下高强度聚焦超声 (USgHIFU) 消融治疗硬纤维瘤 (DTs) 的安全性和有效性。
A total of 111 patients with histologically proven DTs were included and treated by USgHIFU ablation. The enrolled patients (32 male, 79 female, mean age 29.5 ± 1.0 years) with 145 DTs underwent 188 sessions of HIFU ablation.
共有 111 名组织学证实为 DT 的患者被纳入并接受了 USgHIFU 消融治疗。 入组患者（32 名男性，79 名女性，平均年龄 29.5±1.0 岁）进行了 145 次 DT，接受了 188 次 HIFU 消融。
In the majority of cases (143/145 cases, 98.6%), no serious adverse events were observed. The non-perfused area was observed within every treated tumour, and the median NPVR was 84.9% (range, 1.9–100%). The tumour volume reduction rate was 36.1 ± 4.2% at 3 months after treatment.
多数病例中（143/145 例，98.6%）没有发现严重并发症。 治疗肿瘤的非灌注区域，中位 NPVR 为 84.9%（范围，1.9-100%）。治疗后3个月肿瘤体积缩小率为36.1±4.2%。
|
|
Read More >
|
Tech Update in Gynaecological Endoscopy 妇科腔镜技术最新进展
|
Learning Laparoscopic Radical Hysterectomy: Are We Facing an Emerging Situation?
学习腹腔镜根治性子宫切除术：这会是一个新的问题吗？
|
|
In this review, the author presents a brief overview of the learning curve of radical hysterectomy for cervical cancer by laparotomy and laparoscopy. They also discuss factors that might be influencing this learning curve, such as the major effect of The Laparoscopic Approach for Cervical Cancer (LACC) trial and the declining incidence of radical hysterectomies.
在这篇综述中，作者简要概述了通过剖腹和腹腔镜治疗宫颈癌的根治性子宫切除术的学习曲线。他们还讨论了可能影响这一学习曲线的因素，如 LACC 试验的主要效果和根治性子宫切除术发病率的下降。
According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement, they conclude that radical hysterectomy is definitely a procedure declining in numbers due to extensive screening and early detection. Surgical proficiency requires a minimum number of cases performed before becoming autonomous; thus, a learning curve is getting more and more challenging to achieve, especially regarding systematic lymph node aortic staging. For residents and fellows, graduating without conducting this learning curve and performing a laparoscopic radical hysterectomy will not only lead to complications, but also affect the oncological process and, thus, survival.
根据首选系统评价和荟萃分析 (PRISM) 的报告，他们得出结论，由于广泛的筛查和早期发现，根治性子宫切除术的数量肯定在下降。熟练的外科手术要求在独立前完成最少的病例数；因此，学习曲线变得越来越难实现，特别是关于系统的淋巴结主动脉分期。对于住院医师和研究员来说，在没有达到这一学习曲线的情况下毕业并进行腹腔镜根治性子宫切除术不仅会导致并发症，而且还会影响肿瘤过程，从而影响生存。
Do the medical authorities in different countries need to newly propose a different pattern for training or allocate specific centres with special programs for training for laparoscopic radical hysterectomy? This is an emerging situation that definitely needs to be addressed in the near future.
不同国家的医疗主管部门是否需要重新提出不同的培训模式，或者分配专门的中心进行腹腔镜根治性子宫切除术的培训?这是一个新出现的问题，需要在不久的将来加以解决。
|
|
Read More >
|
|
|
|
|
|
|
|
No.359, Jingdongfang Avenue, Beibei District, Chongqing, P.R.China
|
|
|
|
|
|
|
|
+86 23 67886199
